ARCA biopharma Company Profile (NASDAQ:ABIO)

About ARCA biopharma

ARCA biopharma logoARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical trial for the treatment of atrial fibrillation (AF) in patients with heart failure with reduced left ventricular ejection fraction (HFREF). Gencaro is considered part of the beta-blocker class of compounds because of its property of blocking both beta-1 and beta-2, receptors in the heart. The blocking of these receptors prevents the receptor from binding with other molecules, primarily the neurotransmitter norepinephrine (NE), which activate these receptors. The Company is conducting a Phase IIB/III clinical trial of Gencaro, known as GENETIC-AF.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ABIO
  • CUSIP:
Key Metrics:
  • Previous Close: $2.91
  • 50 Day Moving Average: $2.94
  • 200 Day Moving Average: $3.25
  • 52-Week Range: $2.73 - $6.97
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.39
  • P/E Growth: 0.00
  • Market Cap: $25.75M
  • Outstanding Shares: 9,066,000
  • Beta: 1.45
Profitability:
  • Return on Equity: -37.40%
  • Return on Assets: -35.70%
Debt:
  • Current Ratio: 15.82%
  • Quick Ratio: 15.82%
Additional Links:
Companies Related to ARCA biopharma:

Analyst Ratings

Consensus Ratings for ARCA biopharma (NASDAQ:ABIO) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $4.00 (40.35% upside)

Analysts' Ratings History for ARCA biopharma (NASDAQ:ABIO)
Show:
DateFirmActionRatingPrice TargetDetails
2/23/2016Royal Bank Of CanadaReiterated RatingSector Perform$5.00 -> $4.00View Rating Details
2/23/2016Cowen and CompanyReiterated RatingMarket Perform$5.50 -> $4.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for ARCA biopharma (NASDAQ:ABIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/9/2016Q216($0.43)ViewN/AView Earnings Details
11/21/2014($0.15)($0.11)ViewN/AView Earnings Details
8/19/2014($0.13)($0.11)ViewN/AView Earnings Details
5/29/2014($0.12)($0.13)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ARCA biopharma (NASDAQ:ABIO)
Current Year EPS Consensus Estimate: $-1.75 EPS
Next Year EPS Consensus Estimate: $-1.19 EPS

Dividends

Dividend History for ARCA biopharma (NASDAQ:ABIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ARCA biopharma (NASDAQ:ABIO)
Insider Ownership Percentage: 2.46%
Institutional Ownership Percentage: 66.45%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/20/2016Christopher David OzeroffVPSell1,185$2.89$3,424.65View SEC Filing  
9/20/2016Michael R. BristowInsiderSell1,972$2.89$5,699.08View SEC Filing  
9/20/2016Thomas A. KeuerCOOSell714$2.89$2,063.46View SEC Filing  
9/19/2016Brian L. SelbyVPSell476$2.91$1,385.16View SEC Filing  
4/5/2016Christopher David OzeroffVPSell366$3.52$1,288.32View SEC Filing  
4/5/2016Michael R BristowInsiderSell724$3.52$2,548.48View SEC Filing  
4/5/2016Thomas A KeuerCOOSell384$3.52$1,351.68View SEC Filing  
4/4/2016Brian L SelbyVPSell1,114$3.52$3,921.28View SEC Filing  
3/1/2016Christopher David OzeroffVPSell458$3.51$1,607.58View SEC Filing  
3/1/2016Michael R. BristowInsiderSell752$3.50$2,632.00View SEC Filing  
3/1/2016Thomas A. KeuerCOOSell457$3.53$1,613.21View SEC Filing  
9/18/2015Christopher David OzeroffVPSell1,129$6.32$7,135.28View SEC Filing  
3/2/2015Brian L SelbyVPSell1,125$0.71$798.75View SEC Filing  
3/2/2015Michael R BristowInsiderSell5,446$0.71$3,866.66View SEC Filing  
1/16/2015Riley MccormackMajor ShareholderSell350,000$0.76$266,000.00View SEC Filing  
1/7/2015Riley MccormackMajor ShareholderSell550,000$0.92$506,000.00View SEC Filing  
9/18/2014Michael R BristowCEOSell13,853$1.30$18,008.90View SEC Filing  
9/18/2014Patrick M WheelerCFOSell8,246$1.31$10,802.26View SEC Filing  
2/4/2014Riley MccormackMajor ShareholderBuy1,000,000$1.70$1,700,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ARCA biopharma (NASDAQ:ABIO)
DateHeadline
4-traders.com logoARCA Biopharma : Assigned Patent (NASDAQ:ABIO)
www.4-traders.com - September 22 at 3:15 PM
finance.yahoo.com logoARCA biopharma Named Winner of Corporate LiveWire Healthcare and Lifesciences Innovation Award (NASDAQ:ABIO)
finance.yahoo.com - September 13 at 3:15 PM
rttnews.com logoEARS Faces The Music, ABIO On Track, TEVA Gets EU Nod For Asthma Drug (NASDAQ:ABIO)
www.rttnews.com - August 19 at 11:29 AM
4-traders.com logoARCA BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:ABIO)
www.4-traders.com - August 18 at 8:39 PM
reuters.com logoBRIEF-Arca says 100th patient randomized into the genetic-AF phase 2b/3 clinical trial (NASDAQ:ABIO)
www.reuters.com - August 18 at 3:15 PM
publicnow.com logoARCA biopharma Announces 100th Patient Randomized into the Genetic-AF Phase 2B/3 Clinical Trial (NASDAQ:ABIO)
www.publicnow.com - August 18 at 11:39 AM
4-traders.com logoARCA biopharma : Announces Second Quarter 2016 Financial Results and Provides Business Update (NASDAQ:ABIO)
www.4-traders.com - August 9 at 8:50 PM
publicnow.com logoARCA biopharma Announces Second Quarter 2016 Financial Results and Provides Business Update (NASDAQ:ABIO)
www.publicnow.com - August 9 at 8:50 PM
capitalcube.com logoAlbioma :ABIO-FR: Earnings Analysis: For the six months ended June 30, 2016 : August 3, 2016 (NASDAQ:ABIO)
www.capitalcube.com - August 3 at 11:48 AM
streetinsider.com logoForm 4 ARCA biopharma, Inc. For: Jun 09 Filed by: Selby Brian L. (NASDAQ:ABIO)
www.streetinsider.com - June 15 at 3:16 PM
4-traders.com logoARCA BIOPHARMA, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K) (NASDAQ:ABIO)
www.4-traders.com - June 15 at 3:16 PM
biz.yahoo.com logoARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o (NASDAQ:ABIO)
biz.yahoo.com - June 13 at 5:01 PM
businesswire.com logoARCA biopharma Announces First Quarter 2016 Financial Results and Provides Business Update - Business Wire (press release) (NASDAQ:ABIO)
www.businesswire.com - May 12 at 9:47 AM
publicnow.com logoARCA biopharma Announces First Quarter 2016 Financial Results and Provides Business Update (NASDAQ:ABIO)
www.publicnow.com - May 11 at 7:07 PM
biz.yahoo.com logoARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:ABIO)
biz.yahoo.com - May 11 at 4:49 PM
News IconARCA Biopharma, Inc. (ABIO) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:ABIO)
www.sharetrading.news - May 8 at 8:44 AM
News IconBroker Roundup For ARCA Biopharma, Inc. (ABIO) - Share Trading News (NASDAQ:ABIO)
www.sharetrading.news - May 5 at 9:16 AM
News IconLatest Analyst Ratings For ARCA Biopharma, Inc. (ABIO) - Share Trading News (NASDAQ:ABIO)
www.sharetrading.news - April 28 at 9:30 AM
cchdailynews.com logoArca Biopharma Inc (NASDAQ:ABIO)'s Company Shares Increased 0.28% After Low Volatility - CCH Daily News (NASDAQ:ABIO)
cchdailynews.com - April 27 at 10:51 AM
News IconNext Weeks Broker Price Targets For ARCA Biopharma, Inc. (ABIO) - Share Trading News (NASDAQ:ABIO)
www.sharetrading.news - April 27 at 10:51 AM
kcregister.com logoInvestors Watch List: ARCA biopharma, Inc. (NASDAQ:ABIO), Idera Pharmaceuticals (NASDAQ:IDRA), EverBank ... - KC Register (NASDAQ:ABIO)
www.kcregister.com - April 26 at 10:20 AM
News IconWhat's in Arca Biopharma Inc After Forming Multiple Bottom? - The Post (NASDAQ:ABIO)
www.bibeypost.com - April 26 at 10:20 AM
News IconPipeline of congestive heart failure (heart failure) market H1 2016published by leading research firm (NASDAQ:ABIO)
www.whatech.com - April 26 at 10:20 AM
News IconArca Biopharma Incorporated (NASDAQ:ABIO) Short Interest Decreased By 10.89% (NASDAQ:ABIO)
www.bibeypost.com - April 26 at 10:20 AM
News IconARCA Biopharma, Inc. (ABIO) Latest Broker Views - Risers & Fallers (NASDAQ:ABIO)
www.risersandfallers.com - April 21 at 10:25 AM
biz.yahoo.com logoARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ABIO)
biz.yahoo.com - April 18 at 4:31 PM
businesswire.com logoARCA biopharma Announces 75th Patient Enrolled in GENETIC-AF Phase 2B/3 Clinical Trial - Business Wire (press release) (NASDAQ:ABIO)
www.businesswire.com - April 18 at 10:27 AM
finance.yahoo.com logoARCA biopharma Announces 75th Patient Enrolled in GENETIC-AF Phase 2B/3 Clinical Trial (NASDAQ:ABIO)
finance.yahoo.com - April 18 at 9:00 AM
News IconArca Biopharma Incorporated (NASDAQ:ABIO) Shorted Shares Decreased By 10.89% - Stock Caller (NASDAQ:ABIO)
www.stockcaller.com - April 15 at 1:22 PM
News IconAnalyst Coverage: ARCA Biopharma, Inc. (ABIO) - Risers & Fallers (NASDAQ:ABIO)
www.risersandfallers.com - April 12 at 1:18 PM
News IconRa Capital Management Lowers stake in Arca Biopharma Inc (ABIO) - The Sussex Pilot (NASDAQ:ABIO)
sussexpilot.com - April 8 at 1:29 PM
News IconWatch for Action: BGC Partners (NASDAQ:BGCP), ARCA biopharma (NASDAQ:ABIO), Vale S.A. (NYSE:VALE ... - Property Mentor (NASDAQ:ABIO)
www.propertymentorgroup.com - April 7 at 1:48 PM
News IconArca Biopharma, Inc. (ABIO) Files Form 4 Insider Selling : Thomas A Keuer Sells 384 Shares - SCSUCollegian (NASDAQ:ABIO)
www.thescsucollegian.com - April 7 at 1:48 PM
News IconBroker Changes For ARCA Biopharma, Inc. (ABIO) - Risers & Fallers (NASDAQ:ABIO)
www.risersandfallers.com - April 5 at 2:52 PM
News IconAfter Last Week What Do Analysts Think Of ARCA Biopharma, Inc. (ABIO) - Share Trading News (NASDAQ:ABIO)
www.sharetrading.news - April 3 at 2:35 PM
News IconArray Bio ends late-stage study of ovarian cancer drug - ETHealthWorld.com (NASDAQ:ABIO)
health.economictimes.indiatimes.com - April 2 at 1:30 PM
News IconARCA Biopharma, Inc. (ABIO) Analyst Review - Risers & Fallers (NASDAQ:ABIO)
www.risersandfallers.com - April 2 at 1:30 PM
News IconAtrial fibrillation 2016 market pipeline review research made available by top research firm (NASDAQ:ABIO)
www.whatech.com - April 2 at 1:30 PM
news.sys-con.com logoNRPB & Pharma Innovation Partnerships 2015 -- Highlights - SYS-CON Media (press release) (NASDAQ:ABIO)
news.sys-con.com - March 30 at 2:39 PM
News IconVhcp Management Lowers stake in Arca Biopharma Inc (ABIO) - Los Angeles Mirror (NASDAQ:ABIO)
www.losangelesmirror.net - March 30 at 2:39 PM
News IconIn Focus Stocks: ARCA biopharma (NASDAQ:ABIO), Advanced Energy Industries (NASDAQ:AEIS), Shell Midstream ... - Property Mentor (NASDAQ:ABIO)
www.propertymentorgroup.com - March 26 at 2:27 PM
News IconAnalyst Coverage Updates - ARCA Biopharma, Inc. (ABIO) - Risers & Fallers (NASDAQ:ABIO)
www.risersandfallers.com - March 26 at 2:27 PM
finance.yahoo.com logoARCA BIOPHARMA, INC. Financials (NASDAQ:ABIO)
finance.yahoo.com - March 23 at 1:04 PM
News IconAfter Last Week What Do Analysts Think Of ARCA Biopharma, Inc. (ABIO)? - Risers & Fallers (NASDAQ:ABIO)
www.risersandfallers.com - March 20 at 2:51 PM
nasdaq.com logoTTHI, HBIO Put On Notice, Elite Gets FDA Date, VYGR Gets Ready To Sail - Nasdaq (NASDAQ:ABIO)
www.nasdaq.com - March 19 at 12:56 PM
biz.yahoo.com logoARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi (NASDAQ:ABIO)
biz.yahoo.com - March 17 at 4:44 PM
finance.yahoo.com logoBearish case for Valeant (NASDAQ:ABIO)
finance.yahoo.com - March 17 at 2:25 PM
finance.yahoo.com logoGENETIC-AF Clinical Trial for Prevention of Atrial Fibrillation Enrolls 50th Patient (NASDAQ:ABIO)
finance.yahoo.com - January 12 at 8:30 AM
finance.yahoo.com logoApplying Lessons from KBIO (NASDAQ:ABIO)
finance.yahoo.com - December 8 at 9:00 AM
finance.yahoo.com logo2 Micro-Cap Opportunities in Atrial Fibrillation (NASDAQ:ABIO)
finance.yahoo.com - November 30 at 9:38 AM

Social

ARCA biopharma (NASDAQ:ABIO) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff